Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Purple Biotech Ltd. - American Depositary Shares
(NQ:
PPBT
)
1.430
-0.080 (-5.30%)
Delayed Quote
Updated: 1:38 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Purple Biotech Ltd. - American Depositary Shares
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 29, 2025
Via
Benzinga
Purple Biotech Achieves Manufacturing Milestone for IM1240, a Tri-Specific Antibody from the CAPTN-3 Platform
October 29, 2025
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Announces Receipt of Nasdaq Minimum Bid Price Notification
October 20, 2025
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Receives Intention to Grant a European Patent Covering NT219 Combinations with Immunotherapies or MEK Inhibitors to Overcome Tumor Resistance
September 10, 2025
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Announces Closing of Up To $18 Million Public Offering $6 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants
September 05, 2025
From
Purple Biotech Ltd.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
↗
September 05, 2025
Via
Benzinga
Unusual volume stocks in Friday's session
↗
September 05, 2025
Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.
Via
Chartmill
Friday's session: top gainers and losers
↗
September 05, 2025
Curious to know what's happening on the US markets in the middle of the day on Friday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
Let's take a look at the stocks that are in motion in today's session.
↗
September 04, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
September 04, 2025
Via
Benzinga
Top stock movements in today's session.
↗
September 04, 2025
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
Via
Chartmill
Which stocks are gapping on Thursday?
↗
September 04, 2025
Traders are paying attention to the gapping stocks in Thursday's session. Let's dive into which stocks are experiencing notable gaps.
Via
Chartmill
Purple Biotech Announces Pricing of Up To $18 Million Public Offering
September 04, 2025
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Announces New Data Supporting the Unique Design of CAPTN-3 Tri-Specific Antibody IM1240 in Collaboration with the Icahn School of Medicine at Mount Sinai
September 04, 2025
From
Purple Biotech Ltd.
Via
GlobeNewswire
Which stocks are moving before the opening bell on Wednesday?
↗
September 03, 2025
Wondering what's happening in Wednesday's pre-market session? Find an overview in this article.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
September 03, 2025
Via
Benzinga
Purple Biotech Expands CAPTN-3 Portfolio with IM1305, a Novel Tri-Specific Antibody Targeting TROP2
September 03, 2025
From
Purple Biotech Ltd.
Via
GlobeNewswire
Here are the top movers in Tuesday's session.
↗
September 02, 2025
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
September 02, 2025
Via
Benzinga
Top movers analysis in the middle of the day on 2025-09-02: top gainers and losers in today's session.
↗
September 02, 2025
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
Via
Chartmill
Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
August 27, 2025
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech CEO Issues Letter to Shareholders Highlighting Pipeline Progress and Clinical Milestones Achieved in First Half of 2025
July 23, 2025
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Highlights Significant Advantages of the Novel CAPTN-3 Tri-Specific Antibody Platform at the EACR 2025 Annual Congress
June 23, 2025
From
Purple Biotech Ltd.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
June 18, 2025
Via
Benzinga
Purple Biotech Announces Initiation of Phase 2 Study of NT219 in Patients with Head and Neck Cancer
June 17, 2025
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Announces Poster Presentation at EACR 2025 on its Novel CAPTN-3 Tri-Specific Antibody Platform
June 04, 2025
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Appoints Shai Lankry as Chief Financial Officer
May 12, 2025
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Reports Final Data from Phase 2 Study of CM24 in Pancreatic Cancer Patients at AACR 2025 Annual Meeting: Improved Outcomes and Significant Efficacy in Biomarker-Enriched Subgroups
April 30, 2025
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Reports Positive NT219 Data at AACR for Colorectal and Head and Neck Cancers
April 28, 2025
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Announces Publication in the Neuro Oncology Journal Demonstrating the Potential of NT219 to Suppress Brain Metastasis of Colorectal Cancer
April 16, 2025
From
Purple Biotech Ltd.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
